Skip to main content

Published locations for AHA statement addresses CVD risk in NAFLD

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. AHA statement addresses CVD risk in NAFLD

User login

  • Reset your password
  • /content/aha-statement-addresses-cvd-risk-nafld
  • /familypracticenews/article/253796/lipid-disorders/aha-statement-addresses-cvd-risk-nafld
  • /fedprac/article/253796/lipid-disorders/aha-statement-addresses-cvd-risk-nafld
  • /internalmedicinenews/article/253796/lipid-disorders/aha-statement-addresses-cvd-risk-nafld
  • /clinicalendocrinologynews/article/253796/lipid-disorders/aha-statement-addresses-cvd-risk-nafld
  • /jcomjournal/article/253796/lipid-disorders/aha-statement-addresses-cvd-risk-nafld
  • /ecardiologynews/article/253796/lipid-disorders/aha-statement-addresses-cvd-risk-nafld
  • /cardiology/article/253796/lipid-disorders/aha-statement-addresses-cvd-risk-nafld
  • /endocrinology/article/253796/lipid-disorders/aha-statement-addresses-cvd-risk-nafld
  • /internalmedicine/article/253796/lipid-disorders/aha-statement-addresses-cvd-risk-nafld
  • /familymedicine/article/253796/lipid-disorders/aha-statement-addresses-cvd-risk-nafld
  • /emergencymedicine/article/253796/lipid-disorders/aha-statement-addresses-cvd-risk-nafld
  • /type-2-diabetes-icymi/article/253796/lipid-disorders/aha-statement-addresses-cvd-risk-nafld